The key entity of a DCAR agonist, phosphatidylinositol mannoside Ac1PIM1: Its synthesis and immunomodulatory function

Yohei Arai, Shota Torigoe, Takanori Matsumaru, Sho Yamasaki, Yukari Fujimoto

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Ac1PIM1is a potential biosynthetic intermediate for phosphatidylinositol mannosides (PIMs) fromMycobacterium tuberculosis. We achieved the first synthesis of Ac1PIM1by utilizing an allyl-type protecting group strategy and regioselective phosphorylation of inositol. A very potent agonist of an innate immune receptor DCAR, which is better than previously known agonists, is demonstrated.

Original languageEnglish
Pages (from-to)3659-3663
Number of pages5
JournalOrganic and Biomolecular Chemistry
Issue number19
Publication statusPublished - 2020 May 21

ASJC Scopus subject areas

  • Biochemistry
  • Physical and Theoretical Chemistry
  • Organic Chemistry


Dive into the research topics of 'The key entity of a DCAR agonist, phosphatidylinositol mannoside Ac<sub>1</sub>PIM<sub>1</sub>: Its synthesis and immunomodulatory function'. Together they form a unique fingerprint.

Cite this